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Abstract
The last sixty years of research have provided extraordinary advances of our knowledge of the
reward system. Since its initial discovery as a neurotransmitter by Carlsson and colleagues
(Carlsson et al., 1957), dopamine (DA) has emerged as an important mediator of reward
processing. As a result, a number of electrochemical techniques have been developed to directly
measure DA levels in the brain using various preparations. Many of these techniques and
preparations differ in the types of questions that they can address. Together, these techniques have
begun to elucidate the complex roles of tonic and phasic DA signaling in reward processing and in
addiction. In this review, we will first provide a guide for the most commonly used
electrochemical methods for DA detection and describe their utility in furthering our knowledge
about DA's role in reward and addiction. Second, we will review the value of common in vitro and
in vivo preparations and describe their ability to address different types of questions. Last, we will
review recent data that has provided new insight of the mechanisms of in vivo phasic DA
signaling and its role in reward processing and reward-mediated behavior.
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2. Reward circuitry: a brief historical perspective
The neural system that has come to be known as the “reward pathway” in brain was
serendipitously discovered by Olds & Milner when they made the observation that rats
would spend more time in the corner of a chamber where they had previously been given
non-contingent intracranial electrical stimulation (Olds and Milner, 1954). Additionally,
they demonstrated that rats would perform an operant response to receive intracranial self-
stimulation (ICSS) only in specific brain regions and would extinguish responding when the
stimulation was no longer available, establishing that ICSS is positively reinforcing (Olds
and Milner, 1954). Further experiments aimed at mapping the reward pathway indicated that
brain regions along the medial forebrain bundle, a fiber tract known to connect the midbrain
tegmentum and limbic regions, supported the most robust ICSS (for review see (Olds and
Fobes, 1981)). Specifically, several nuclei along the mesocorticolimbic dopaminergic
pathway were shown to support ICSS including the ventral tegmental area, dorsal striatum,
nucleus accumbens and medial prefrontal cortex (Crow, 1972, Phillips et al., 1975, Mora et
al., 1976, Phillips et al., 1976). Alterations in these nuclei have subsequently been shown to
play a role in many psychiatric disorders, including drug addiction.
Early research demonstrated that pharmacological manipulations of catecholamine signaling
within the mesocorticolimbic pathway altered ICSS such that compounds that increase
extracellular catecholamines, like amphetamine and cocaine, facilitate ICSS and those that
block catecholamine signaling at the receptor level decrease ICSS (Stein, 1964, Crow, 1970,
Ranaldi and Beninger, 1994). While it was initially thought that these findings indicated a
significant role for norepinephrine neurotransmission in maintaining ICSS, a more critical
role for DA neurotransmission soon emerged (Fibiger, 1978). While the pharmacological
manipulations used to characterize the effects of catecholaminergic neurotransmission on
ICSS do alter norepinephrine signaling, they also affect the dopaminergic system. Evidence
indicating that norepinephrine is not a critical component for ICSS was provided in studies
showing that in rats displaying stable ICSS, depletion of norepinephrine behavior had no
effect on ICSS nor did it affect amphetamine-induced enhancement of ICSS (Lippa et al.,
1973, Cooper et al., 1974). However, selective decreases in DA levels reduce ICSS and
decrease amphetamine-induced enhancement of ICSS (Liebman and Butcher, 1973, Lippa et
al., 1973, Cooper et al., 1974). Further studies demonstrated that lesions of ascending
noradrenergic pathways did not disrupt ICSS, while lesions of ascending dopaminergic
pathways reduced ICSS (Clavier and Fibiger, 1977, Phillips and Fibiger, 1978). While other
neurotransmitter systems likely contribute to ICSS behavior, these studies indicated a
prominent role for DA.
Research indicating that both ICSS and modulation of ICSS behavior by psychostimulants
are dependent upon dopaminergic mechanisms provided the basis for the DA hypothesis of
drug reward, which posits that drugs of abuse are rewarding because they increase
mesolimbic dopaminergic neurotransmission (Wise and Rompre, 1989). As further
evidence, self-administration of psychostimulants such as amphetamine, cocaine and
nicotine increase extracellular DA in the nucleus accumbens (NAc) (Hurd et al., 1989, Hurd
et al., 1990, Di Ciano et al., 1995, Lecca et al., 2006). In addition, studies revealed that
animals will self-administer drugs of abuse into specific brain regions of the mesolimbic
pathway. For instance, direct infusion of cocaine or amphetamine into the NAc shell and
nicotine infusion into the ventral tegmental area (VTA) are sufficient to support self-
administration behavior (Hoebel et al., 1983, Carlezon et al., 1995). In light of these
findings, particular attention has been given to the dopaminergic neurons of the VTA and
their target regions including the NAc and prefrontal cortex and their role in drug reward.
The NAc is particularly implicated in drug-seeking behavior as the region where
information from limbic regions and the prefrontal cortex is integrated and translated into
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behavioral output (Mogenson et al., 1980, Goto and Grace, 2008). Thus, changes in tonic
(on the order of minutes) or phasic (on the order of seconds) DA have been analyzed under
various experimental conditions in order to understand the role of DA dynamics in reward.
In the next section, we will review a number of methodologies and preparations that have
been used in these research efforts.
3. Methods for analysis of DA dynamics
DA neurons can fire in either a tonic or phasic-like mode. Tonic activity is characterized by
3 to 8 Hz firing frequencies while phasic firing is characterized by bursts of action potentials
with a frequency of ∼12 to ∼20 Hz (Grace and Bunney, 1984a, b, Hyland et al., 2002). The
firing patterns of DA neurons are minimally modulated during sleep or anesthesia, although
different stages of wakefulness can modulate their activity (Miller et al., 1983, Freeman et
al., 1985). This neuronal firing leads to the release of DA from presynaptic terminals into
the extracellular space, where it binds to receptors. DA receptors are also present in the
extrasynaptic space and DA signaling is characterized by “volume transmission” where DA
diffuses from the synapse and binds to extrasynaptic receptors to initiate downstream
processes (Rice and Cragg, 2008). The levels of extracellular DA in target regions are
regulated by four main processes: diffusion, neuronal firing, vesicular release from pre-
synaptic terminals and reuptake by the DA transporter (DAT). Further, drugs of abuse
typically exert their effects by altering one or more of these processes (Sulzer, 2011). Thus,
various methods have been used to measure changes in DA concentration as well as specific
changes in DA release and uptake. Among these approaches are microdialysis,
electrochemical-based techniques using carbon fiber electrodes (CFE’s) (amperometry,
chronoamperometry, fast-scan cyclic voltammetry (FSCV)), rotating disk voltammetry
(RDV), and radiolabeling methodologies. Furthermore, a number of additional preparations
have been combined with the above techniques. Advantages and disadvantages of using in
vitro (synaptosomes, single cell, tissue) and in vivo (anesthetized and awake-behaving
animals) techniques will be discussed below, using specific examples from the literature
highlighting their advantages, as well as their compatibilities, with DA detection methods.
3.1. Microdialysis
Microdialysis is one of the most commonly used methods to measure neurotransmitter levels
in the extracellular space of the brain. The microdialysis technique evolved from the push-
pull cannula, an arrangement of two concentric tubes that allowed fluid to be directed into
the brain and then removed. First described in the late 1960s and practically implemented in
the early 1970s (Delgado et al., 1972, Ungerstedt and Pycock, 1974), over 10,000 papers
have been published examining DA levels in the brain using some form of microdialysis
(key word search: DA and microdialysis, Web of Knowledge database). Microdialysis itself
is a collection method and is not to be confused with methods that are often used in
conjunction with microdialysis to detect analytes of interest (i.e. DA). The microdialysis
probe consists of a semi-permeable membrane that allows small molecules to pass through
(<20 Kd). Typically, a physiological salt solution, such as artificial cerebral spinal fluid
(aCSF), is infused through the microdialysis probe. Since most analytes of interest, such as
DA, are not in aCSF, they will diffuse down their concentration gradient and across the
dialysis probe to be collected and sent to a detector.
Ultimately, the samples collected via microdialysis must be analyzed. Typically the volumes
of samples collected are on the order of microliters, therefore, the amount of analyte is very
low, often in the femtomole range. Thus, the methods used to analyze dialysate samples
must be very sensitive. The most common detection methods used in conjunction with
microdialysis are chromotagraphic-based techniques, such as gas (GC) and high-
performance liquid chromatography (HPLC). GC is generally too insensitive for measuring
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neurotransmitters, therefore, HPLC is typically employed. HPLC uses stationary phases that
are contained in columns. The mobile phase and sample are pumped into the HPLC column.
Each analyte in the sample will interact differently with the stationary phase, which will
produce different retention times, or time it takes to emerge from the column. The retention
time typically serves as a unique characteristic of an analyte and therefore provides
selectivity for this technique. HPLC is usually coupled with a sensitive detection scheme
such as electrochemical detection (EC) (Westerink and Van Oene, 1980), florescence
(Anderson and Young, 1981), ultraviolet (UV) (Gagnieu et al., 1984), or mass spectrometry
(MS) (Bronaugh et al., 1975, Zhang et al., 2007).
Microdialysis with HPLC-EC is one of the most common analytical methods for the
detection of DA in vivo, and is best suited to determine long-lasting changes in extracellular
DA concentration. To determine absolute DA concentration, the “no-net flux” method is
used where several known concentrations of the analyte (such as DA) are perfused through
the dialysis probe until equilibrium is reached. When equilibrium is reached, the
concentration of analyte at the sampling site equals the concentration of analyte in the
perfusate thus allowing estimation of the analyte at the sampling site.
The limits of temporal resolution for microdialysis are usually limited by the detection
method employed. Finer temporal resolution requires better mass detection methods.
HPLC’s detection limit requires sample times of 5–10 minutes. However, recent
advancements in HPLC has allowed temporal resolution to decrease to 1–2 minutes by
decreasing the inner diameter of the HPLC column (from 4–5 mm to 0.3–1 mm), resulting in
less dilution of the analyte prior to reaching the detector. A more recent advance in detection
methods utilized with microdialysis is capillary liquid chromatography (cLC). cLC columns
have very small inner diameters (25–150 µm) and, when combined with electrochemical
detection methods, can provide temporal resolution as high as 10 seconds (Schultz and
Kennedy, 2008).
Microdialysis, coupled with even the most sensitive detection methods, has low temporal
resolution (tens of seconds to minutes) compared to the techniques discussed below.
However, low temporal resolution is advantageous in some instances. For example, basal,
steady-state levels of DA are best assessed using a method with lower temporal resolution.
Imperato and Di Chiara used microdialysis to show that ethanol, nicotine, amphetamine and
cocaine increase DA levels in the NAc leading the authors to suggest that stimulation of DA
transmission in the mesolimbic system may be a pertinent characteristic of drugs of abuse
(Imperato and Di Chiara, 1986, Di Chiara and Imperato, 1988). Although the
aforementioned techniques have advanced our knowledge about neurotransmitter systems,
the temporal resolution limits the questions they can address. Changes in DA levels on the
scale of minutes and hours surely contribute to behavior. However, subsecond changes in
DA levels correlates with several fundamental aspects of behavior, such as learning, reward
and cue processing, saliency, and motivation. Furthermore, measurements of subsecond DA
levels allow estimation of DA transporter functioning (DAT), which may play a role in the
pathology of addiction. Below, several common techniques to assess subsecond DA levels
will be discussed.
3.2. Amperometry
Two types of amperometry have been used to monitor DA. Constant potential amperometry,
typically referred to as amperometry, is an electrochemical technique that provides high
temporal resolution with limited selectivity. In this method, a constant, continuous potential
is applied to the working electrode and the current produced is directly proportional to the
number of molecules undergoing oxidation and reduction (Michael and Wightman, 1999a,
Willuhn et al., 2010). If maximal temporal resolution is desired, then amperometry is ideal
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as it can be used to detect individual exocytotic events and provide estimates of quantal
release in single cells (Mundroff and Wightman, 2002). The limitation of amperometry is
that the current produced by the oxidation or reduction of all molecules at the applied
potential will also be detected, limiting specificity. However, the technique can be used for
monitoring electrically-stimulated DA in various preparations, by confirming the validity of
the signal with anatomical, pharmacological and physiological data (Dugast et al., 1994).
Additionally, constant potential amperometry can be combined with enzyme-based detection
systems to detect non-electroactive analytes, such as acetylcholine. In chronoamperometry,
the potential is periodically pulsed to a value sufficient to oxidize DA (Gulley et al., 2007).
Some chemical selectivity is obtained by monitoring the ratio of the current when the
potential is returned to its initial value relative to that measured during the potential step.
This current ratio is determined by the stability of the electrogenerated product.
Additionally, Nafion, a cation exchange membrane, can be coated on the electrode to limit
access of anionic species. Coating the carbon fiber with Nafion can also be applied to other
voltametric techniques (discussed below). Microdialysis coupled with HPLC, however,
allows for enhanced chemical selectivity compared to chronoamperometry. Amperometry
may also be used in conjunction with Michaelis-Menten based modeling in order gauge
functioning of the DA transporter (DAT).
3.3. Fast-Scan Cyclic Voltammetry
Fast scan cyclic voltammetry (FSCV) provides high chemical selectivity and temporal
resolution. During FSCV, the potential at the working electrode is applied as a triangular
waveform, and the time between scans is about ten times as long as the time of the scan
itself. This allows the cyclic voltammograms to be recorded with high temporal resolution,
typically repeated at 10 Hz. While this is very good temporal resolution, it is lower than the
resolution possible with constant potential amperometry. In FSCV, current is generated at
different potentials and the electrolysis of different species is manifested as distinct peaks.
The background current in FSCV is stable over short periods of time, allowing it to be
digitally subtracted. The resulting background-subtracted cyclic voltammogram (CV)
provides an electrochemical “fingerprint” revealing the identity of the analyte detected
(Michael and Wightman, 1999a). FSCV is further advantageous in that the cyclic
voltammogram is able to separate the signal of interest from most interferents such as pH
through the use of principal component regression to statistically identify DA events (Heien
et al., 2004). However, brain regions for DA detection must be carefully selected as the CV
for DA is almost indistinguishable from the CV for norepinephrine (NE). Thus, FSCV
experiments are typically performed in areas that contain primarily DA or NE. Despite this
limitation, FSCV has been used to characterize phasic DA release during reward-seeking
behaviors, specifically, showing that the learning of reward-predicting cues correlates to
cue-evoked DA release in the NAc (Owesson-White et al., 2008).
FSCV can be used to determine the kinetics of DAT function. Altered DAT functioning can
cause three major changes to DA neurotransmission. First, postsynaptic DA receptors may
only detect changes in the magnitude of DA release without changes in timing (amplitude-
modulated signal). Second, alterations in DAT function can cause a “spread” of the DA
signal in time, without changes in magnitude (frequency-modulated signal). Third, both
amplitude-modulated and frequency-modulated signal changes can occur (Schenk et al.,
1990, Earles et al., 1998, Schenk et al., 2005). These changes in chemical neurotransmission
can lead to alterations in the typical physiological functioning. For example, acute and
chronic cocaine exposure can cause changes in DAT functioning, which may play a role in
cocaine addiction (Addy et al., 2010)
Kinetic modeling has been most useful in slice and anesthetized preparations (Wightman et
al., 1988, Jones et al., 1999, Miles et al., 2002, Robinson et al., 2005). The random walk
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approach, employed in brain slices, uses a Michaelis-Menten based model of uptake coupled
to diffusion and release (Schmitz et al., 2001). In both brain slice and in vivo anesthetized
preparations, non-linear regression and single curve fitting analyses have been used to
determine DA release and uptake kinetics (Garris and Wightman, 1994, Wu et al., 2001).
Specifically, the major parameters of interest are [DA]p, the concentration of dopamine
released per stimulation pulse, Vmax, the maximal rate of uptake (that reflects the efficiency
at which DAT removes DA), and Km, the concentration of DA substrate at which half of
Vmax occurs. Different regions of the brain exhibit different Vmax values for DA. However,
Km and Vmax are fairly consistent across FSCV in both slice (Jones et al., 1995a, Jones et
al., 1995b, Jones et al., 1996) and anesthetized preparations (Garris et al., 1994, Cass and
Gerhardt, 1995, Mickelson et al., 1998, Wu et al., 2001, Addy et al., 2010) and are
consistent with values obtained using [3H] DA radiolabeling techniques (described below).
For example, Km is usually reported in the range of 0.1µM to 0.3µM in the caudate-putamen
and nucleus accumbens, with a mean of 0.2µM. (Garris et al., 1994).
3.4. Rotating Disk Voltammetry
Rotating Disk Voltammetry (RDV) provides the most accurate measurements of transport
activity. RDE theory is based on the idea of a plane with infinitesimal thickness that is
rotating about its axis in solution at a constant rate (Earles et al., 1998). This motion creates
drag, which pulls the solution in a direction perpendicular to the electrode. The analyte of
interest is brought towards the electrode and then spun radially away via centrifugal forces.
If the analyte is electroactive, then RDV can be applied to oxidize or reduce the analyte and
produce a current proportional to the analyte concentration. Typically, the applied voltage is
fixed at a value sufficient to electrolyze the analyte. Because of the requirement of a liquid
sample, RDV is used in synaptosomal preparations, or cell or tissue suspensions.
In the context of DA uptake, diffusion can confound interpretation of results obtained with
electrochemical approaches. However, an advantage of RDV is the solution is in constant
flux; therefore, the effects of mass transport and diffusion processes are minimized,
enhancing the quality of transport measurements with this technique. In RDV experiments,
DAT kinetics are determined using non-linear curve fitting that is based on Michaelis-
Menten kinetics (Schenk et al., 2005). A drawback of RDV is that it cannot be used in vivo
since the methodology is centered around rotation of the solution (Earles et al., 1998).
3.5. [3H] DA radiolabeling and DA radioligand binding
Although not an electrochemical technique per se, radiolabeling techniques are important
given their extensive use in the measurements of DA uptake. The general approach is to
incubate synaptosomes or tissue slices with [3H] DA, wash off the extracellular fluid, and
measure via liquid scintillation counting, the radioactivity accumulated in the tissue (Brown
et al., 2002, Fleckenstein et al., 2002). The amount of labeled DA that enters the tissue can
provide an estimate of DA uptake. An alternative approach to studying DAT is to use a
radioligand that binds to DAT. This approach provides a quantitative estimate of DAT
number and location, rather than DA function.
3.6. Optical methods for monitoring presynaptic DA release
Fluorescent styryl dyes, such as FM1–43, are useful tools to monitor the endocytosis and
exocytosis of neuronal synaptic vesicles. FM1–43 can be packaged and released with
endogenous neurotransmitters. Therefore, neurotransmitter release can be indirectly
measured by detecting changes in the intensity of florescence produced by FM1–43,
typically detected by two-photon microscopy. This approach is most often used with in vitro
preparations such as tissue slices and cell cultures (Angleson et al., 1999, Bamford et al.,
2004, Geldwert et al., 2006, Bamford et al., 2008). There are two major stages for optically
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monitoring neurotransmitter release using FM1–43: staining and destaining. Staining is
accomplished by bath application of FM1–43 to the preparation followed by electrical
stimulation of cells or terminal fields to provoke endocytosis of the dye followed by a
washout period. Destaining is the process caused by a second electrical stimulation, which
should release vesicles that contain FM1–43. After stimulation, the intensity of florescence
produced by FM1–43 decreases, indicating vesicular release. The change in florescence is a
proxy for neurotransmitter release.
Deciding which particular DA detection method can best achieve an experiment’s desired
goals is crucial. The utilization of each of the methods described above in the various in
vitro and in vivo preparations is detailed below.
4. Experimental Preparations
4.1. Synaptosomal Preparations
Synapotosomes are the simplest preparation to study neurotransmitter release and uptake
(Nicholls, 2003). Synaptosomes are isolated nerve terminals or varicosities whose axonal
attachments have been removed by shearing the tissue in an isosmotic solution (Nicholls,
2003). In addition, synaptosomes can be used to isolate synaptic vesicles allowing the direct
study of release and uptake of DA at the vesicular level. Using synaptosomes, two common
techniques have been employed to measure release and uptake kinetics with similar levels of
accuracy. These are[3H] DA radiolabeling and RDV, the former being the most popular.
Several important questions about DA uptake and release have been resolved through
synaptosomal preparations. Using synaptosomes in conjunction with radiolabeling, the
kinetics of DA uptake have been investigated in rat caudate and NAc (Krueger, 1990,
McElvain and Schenk, 1992c, a, b, Povlock and Schenk, 1997). Radiolabeling was initially
used for uptake characterization and provided evidence for a transporter-mediated uptake
system. Subsequent work using RDV extended this work to determine how drugs of abuse
modulate DA kinetics (Schenk et al., 1990, McElvain and Schenk, 1992c, a, b, Povlock and
Schenk, 1997). More direct measurements of DA uptake were subsequently performed using
both RDV and radiolabeling through the isolation of synaptic vesicles (Volz et al., 2006,
Volz et al., 2007).
In addition to studying basic mechanisms of DA release and uptake, synaptosomal
preparations have also revealed information about specific presynaptic receptors mediating
DA release. For example, Grady et. al. demonstrated with [3H] DA radiolabeling that β2
containing nicotinic acetylcholine receptors (nAchR) were required for acetylcholine-
induced DA release from the striatal, NAcc, olfactory tubercle, and prefrontal cortex
synaptosomes (Grady et al., 2002). These studies highlight uses for synaptosome
preparations in studying uptake and release in both intact axon terminals as well as synaptic
vesicles (Volz et al., 2006, Volz et al., 2007, Farnsworth et al., 2009).
In comparison to RDV, radiolabeling is more sensitive and can be used to measure DA in
sparsely innervated regions. In the experiment by Grady and colleagues (Grady et al., 2002)
radiolabeling was most likely used because of the sparse dopaminergic innervations to the
prefrontal cortex. However, it would be difficult to detect such low amounts of DA using
RDV. On the other hand, radiolabeling techniques can be confounded by metabolic
processes which may contaminate the signal measured. For example, DA conversion to
DOPAC can give false readouts of DA, since the tritiatum will also be in DOPAC.
Therefore, radiolabeling has higher sensitivity, while RDV has better selectivity
(Middlemiss and Hutson, 1990).
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4.2. Single cell preparations
Single cell experiments using voltammetry provide excellent spatial and temporal resolution
for measuring neurotransmitter release mechanisms (Michael and Wightman, 1999b, Travis
and Wightman, 1999). This preparation is suitable for use with all electrochemical,
electrophysiological, and radiolabelling techniques which are often used in complement.
The power of using single cell preparations is that measurements can be made with high
spatial accuracy in conjunction with an inverted light microscope. Historically, single cell
preparations using electrochemical detection methods have been utilized to investigate
catecholamine release from vesicles (Leszczyszyn et al., 1990, Wightman et al., 1991, Chow
et al., 1992, Pihel et al., 1994, Travis and Wightman, 1999). Original investigations used
bovine adrenal cells, which contain large vesicles with slow release kinetics on the order of
milliseconds (Leszczyszyn et al., 1990, Wightman et al., 1991), although neuronal cells such
as the giant DA neurons in Planorbus corneus have also been used (Chen et al., 1996, Chen
and Ewing, 1997, Anderson et al., 1998, 1999). The contents of these cells can be measured
beforehand via high pressure liquid chromatography to verify dopaminergic content, which
then allows the use of amperometry for high temporal resolution measurements. However,
when the contents of a cell have more than one major electroactive species, FSCV is
required (Pihel et al., 1994) for chemical selectivity.
Single cell preparations have been used extensively with electrochemical techniques to study
the kinetics of vesicular release in cells (Wightman et al., 1991, Chow et al., 1992, Alvarez
de Toledo et al., 1993, Pihel et al., 1994, Albillos et al., 1997, Travis and Wightman, 1999).
One notable contribution of single cell preparations coupled with electrochemistry is the
finding that catecholamine-containing vesicles may partially fuse with the membrane,
releasing a trace amount catecholamine (Alvarez de Toledo et al., 1993, Albillos et al.,
1997). This finding was critical since it ruled out an “all or none” mechanism of
neurotransmitter release. In addition, extensions of these types of experiments have been
performed in neurons (Zhou and Misler, 1995, Staal et al., 2004).
A special consideration for neuronal measurements of single event release is that neuronal
release is much faster than non-neuronal release. Therefore, the use of amperometry or
FSCV depends largely on the question being asked. Investigations of single event release in
neurons must be measured using amperometry to capture its fast release kinetics, 0.5 ms to 2
ms for dense core vesicles in ganglia (Zhou and Misler, 1995) and about 100 µs for small
synaptic vesicles (Sulzer and Pothos, 2000, Staal et al., 2004), while FSCV is necessary to
identify the released substances (Pihel et al., 1994). Finally, amperometry cannot be used to
directly determine absolute concentrations in DA release. As discussed above,
concentrations are determined using a flow chamber. Since, in single cell preparations, the
electrode is placed on the membrane, the diffusion layer is constrained by the distance from
the electrode to the membrane, rather than by the properties of the electrode itself. This
altered diffusion layer is difficult to reproduce in the flow chamber, hence concentrations are
rarely reported from single cell or tissue (see below) amperometric studies. However, the
number of molecules released in a single event can be quantified by integrating the current.
The integral has units of charge, which, by Faraday’s law, allows direct calculation of the
number of released molecules that were detected. FSCV can be used to measure local
concentrations since its diffusion layer is very small. Therefore, there is negligible
difference between the diffusion layer near a cell membrane and that in a flow chamber
(Michael and Wightman, 1999b).
4.3. Slice preparations
Thin (200–400 µM) slices of brain tissue that are continually perfused with oxygenated
artificial cerebrospinal fluid are viable for several hours (Michael and Wightman, 1999a).
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There are several advantages for using slice preparations. Slices can be placed under a
microscope for more precise anatomical placement of the recording electrode, which gives
this technique greater spatial resolution than that obtained in vivo. Slices are also suitable for
studying the effects of local application of drugs without interference from systemic
processes and without surgical placements of cannulae. Therefore, a known concentration of
drug can be applied to the slice. Measurements are also easier to make in slices due to
enhanced DA release upon electrical stimulation of slices when compared to in vivo
stimulation. The reason for higher concentrations of DA is unclear. One potential
explanation is that electrical stimulation of the slice itself is more likely to activate the
terminals of dopaminergic neurons, whereas in vivo stimulation may activate a smaller
population of terminals and a larger population of cell bodies, which do not depolarize easily
under most stimulation protocols which utilize as small pulse width (∼4ms) (Yeomans,
1979, Yeomans et al., 1979, Yeomans et al., 1988). An alternative contribution could be due
to the demonstrated lack of basal dopamine tone and basal D2 autoreceptor activation in the
slice preparation (Phillips et al., 2002), resulting in little inhibitory tone. Therefore, a
combination of a lack of inhibition coupled with active excitatory input may explain greater
evoked DA release in slices. Additionally, since DA cells are also silent in the slice
preparation (Phillips et al., 2002, Perra et al., 2011), there may be a build-up of presynaptic
vesicles in the slice, leading to greater evoked DA release.
Due to the larger DA release in slices, it is easier to measure uptake kinetics. Multiple brain
regions and multiple slices within a brain region can be used from a single animal, thereby
enhancing the utility of each subject and reducing variability, respectively. The use of brain
slices precludes the use of anesthetics, which may interfere with DA signaling. Finally, the
experimenter has control over the experimental conditions to reduce interference from
temperature and pH fluctuations, unlike in vivo preparations (John and Jones, 2007).
FSCV has been the most common electrochemical technique in brain slices, although brain
slice preparations do not preclude chronoamperometric techniques. Unlike single cell
preparations in which potential analytes can be determined ahead of time, there is no clear
way to determine the analyte species present in the slice. Hence, FSCV is the most
straightforward approach to studying DA uptake in brain slices because of its ability to
identify specific analytes of interest. Caron and coworkers used FSCV in striatal slices to
determine changes in DA uptake mice with genetic deletions of the DAT (Giros et al., 1996,
Jones et al., 1998). The uptake rate was 300 times faster in striatal tissue from wild type
mice than in tissue from the DAT knockout animals whereas the rate of DA uptake in
heterozygous animals was approximately one half of the rate in wild type mice. One goal of
this experiment was to also verify that DAT was the only transporter responsible in the
striatum for DA uptake. Hence, there are three major reasons why Giros et. al chose slice
preparations. First, since there is continually flowing fluid over the slice, the authors were
able to verify that the removal of DA in knockout slices was attributed to diffusion
facilitated by the perfusion fluid. This verification cannot be done easily in vivo. Second,
tissue preparations allow application and wash out of drug. Therefore, when NE and 5-HT
uptake inhibitors were applied and washed out of the tissue, there was no change in uptake
or release in either condition. Ruling out the role of NE and 5-HT transporters is important
because they can also transport DA (Duan and Wang, 2010, Larsen et al., 2011). Third, as
previously stated, larger DA release in slices allows for easier characterization of the
kinetics compared to other preparations. However, some precautions must be taken with
slice preparation as the higher DA release in slices versus in vivo are likely due to
differences in stimulation areas. Whether this is physiologically relevant is unclear. Overall,
however, brain slices with electrochemistry provide a good model for studying release and
uptake in complex systems.
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4.4.In vivo preparations
In vivo DA measurements serve two major purposes—to verify in vitro measurements in the
intact brain, and to allow for simultaneous acquisition of behavioral and electrochemical
data. In vivo anesthetized preparations are the simpler choice when deciding on an in vivo
preparation because the surgeries are less involved than freely-moving surgeries and because
the data acquisition is done in a more controlled environment, providing a larger signal to
noise ratio (Gulley et al., 2007, Robinson and Wightman, 2007). Urethane has been reported
to not interfere with DA signaling, thereby making it a useful drug for anesthetized
preparations (Sabeti et al., 2003). However, awake, freely-moving animals remove any
potential effects of anesthesia on DA signaling and provide behavioral data at the time of
DA recording.
Both microdialysis and voltammetric techniques can be used in vivo. Microdialysis
experiments are conducted most often in awake, behaving animals, but can also be done in
anesthetized preparations. Microdialysis is capable of measuring nanomolar amounts of DA
in the extracellular environment of the brain. Additionally, microdialysis is ideal for
measuring the relatively slow effects of drugs on extracellular concentrations of DA as drug-
induced changes in DA receptor function can be correlated with behavioral changes in
freely-moving animals (Gulley et al., 2007). For example, Chefer et al. showed that
behavioral sensitization to cocaine was correlated with an attenuation of basal DA release
and a diminished ability of quinpirole, a D2 receptor agonist, to inhibit DA release (Chefer
and Shippenberg, 2002).
Although microdialysis offers these advantages and excellent chemical selectivity, it cannot
offer the high spatial or temporal resolution of electrochemical recording techniques. Carbon
fiber electrodes (CFEs) CFEs can be made more than 20-fold smaller than microdialysis
probes (∼7 µm diameter CFEs vs. ∼200 to ∼500 µm diameter microdialysis probes). Their
small size allows for minimal damage when they are implanted into living brain tissue. The
small size also allows for the recording of electrical stimulation events of DA cell bodies
with less diffusional distortion (Borland and Michael, 2007).
Voltammetric methods with CFEs are used in both anesthetized and freely-moving animals.
For example, Gerhardt et al. coupled a microinjection cannula to a CFE, allowing them to
locally apply DA in the mammalian brain. They employed chronoamperometry in freely-
moving animals to compare uptake rates in anesthetized and freely moving animals
(Gerhardt et al., 1999). Chronoamperometry can also be used in anesthetized preparations to
analyze baseline differences in DA function and also the effects of drugs that alter DA
activity. This is less technically challenging than recording in freely-moving animals,
however, data cannot be correlated to behavior (Gulley et al., 2007).
An even more powerful benefit of using FSCV in vivo is that discrete, naturally-occurring
DA signals can be detected in awake rats during behavior (Robinson and Wightman, 2007).
This was first done by Rebec et al. in 1997 in the NAc shell (Rebec et al., 1997). These
naturally-occuring DA signals, or transients, are not time-locked to external stimuli such as
cues and rewards and therefore are likely to reflect either the motivational state of the animal
or spontaneous DA release. In the dorsal and ventral striatum, DA transients occur at
baseline frequencies, an average of 0.24 per minute (Robinson et al., 2002) and vary from 10
nM to over 1 µM in concentration. They increase in frequency at the presentation of salient
stimuli to the animal (Rebec et al., 1997), social interaction (Robinson et al., 2002),
pharmacological application (Cheer et al., 2004), and self-administration of drug reinforcers
(Phillips et al., 2003a). Over the last 10 years, studies employing in vivo FSCV in freely
moving animals have continued to provide new insights of the complex role of phasic DA
signaling in reinforcement learning and reward seeking-behavior.
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5. The role of in vivo DA signaling: recent findings
5.1. Tonic and phasic DA signaling
DA neurons fire in two distinct modes, tonic and burst firing, which leads to different types
of DA release at terminals in target regions. Tonic DA firing occurs at a frequency of 3–8
Hz and leads to DA release that results in steady-state DA levels. In contrast, burst firing
occurs with intra-burst frequencies of ∼12 to ∼20 Hz and leads to transient, phasic increases
in DA concentration ranging from 10 nM to 1 µM (Grace and Bunney, 1983, 1984a,
Freeman et al., 1985, Wightman and Zimmerman, 1990, Hyland et al., 2002, Aragona et al.,
2008). Different regulatory systems are capable of selective modulation of tonic and phasic
DA signaling. For example, glutamatergic/cholinergic afferents from the pedunculopontine
tegmental nucleus (PPT) to the VTA contribute to phasic DA firing/release, whereas
GABAergic input from the ventral pallidum (VP) to the VTA modulates tonic DA/release
(Floresco et al., 2003). Distinct characteristics of phasic and tonic DA firing/release suggest
that these differential temporal dynamics of DA release might have distinct roles in
physiology and behavior. Therefore, distinguishing tonic and phasic contributions of DA
release may shed light on DA-related central nervous disorders such as Parkinson's,
schizophrenia, and addiction.
5.2. Physiological consequences of phasic DA firing
DA neurons in the VTA and substantia nigra (SN) project to the nucleus accumbens (NAc),
dorsal striatum, prefrontal cortex, amygdala and hippocampus. Phasic firing of DA cells
activates excitatory, low affinity DA D1-like receptors, leading to activation of the direct
pathway of the basal ganglia and facilitation of long term potentiation (LTP) at excitatory
cortico-striatal synapses (Goto and Grace, 2005, Grace et al., 2007). In contrast, tonic DA
activity is proposed to activate DA D2-like receptors, producing long term depression (LTD)
of the medium spiny neurons (MNS) within NAc and dorsal striatum and leading to
suppressed activity of indirect pathway of the basal ganglia (Goto and Grace, 2005, Shen et
al., 2008). It has been proposed that coordination of D1 and D2 activation, by controlling
striatal plasticity, modulates motor and cognitive function and facilitates behavioral
flexibility (Shen et al., 2008). In line with these electrophysiological results is the recent
electrochemical data demonstrating that phasic DA signaling in NAc selectively modulates
excitatory but not inhibitory responses of NAc neurons during reward-seeking behavior
(Cacciapaglia et al., 2011). These observations suggest that phasic DA selectively activates
discrete NAc microcircuits that influence goal-directed behaviors (Cacciapaglia et al., 2011).
5.3. Phasic DA signaling is modulated by excitatory afferents
Burst activity of midbrain DA neurons resulting in transient increase in synaptic DA (Grace
et al., 2007) is mediated by large amplitude, slow inactivating excitatory postsynaptic
currents (EPSCs). Burst firing of DA neurons and subsequent DA transients are modulated
by excitatory afferents from the midbrain pedunculopontine tegmental (PPTg) and
laterodorsal tegmental (LDT) nuclei, which process cue-related sensory information to DA
neurons (Lodge and Grace, 2006, Lester et al., 2008, Zweifel et al., 2009). These afferents
have been shown to be both glutamatergic and cholinergic, implicating the involvement of
glutamatergic and/or cholinergic signaling in the modulation of DA neuronal activity.
Indeed, activation of the PPTg results in burst firing in SNc DA cells and striatal phasic DA
release (Floresco et al., 2003) - an effect blocked by intra-SNc infusions of nonselective
nicotinic ACh receptors (nAChRs) antagonists (Forster and Blaha, 2003). In addition, LDT
projections to the VTA have been demonstrated to evoke burst firing of VTA DA cells
(Imperato et al., 1991, Oakman et al., 1995). Specifically, pharmacological activation of the
VTA muscarinic ACh receptors (mAChRs) and nAChRs produces increased DA release in
DA terminals, whereas blockade of VTA mAChRs and nAChRs attenuates phasic DA
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signaling in the NAc (Lacey et al., 1990, Blaha et al., 1996, Floresco et al., 2003, Lester et
al., 2008, Ishibashi et al., 2009). Furthermore, inhibition of nicotinic or muscarinic receptors
in the VTA attenuates LDT stimulated phasic DA signaling in the nucleus accumbens
(Lester et al., 2008).
Glutamatergic mechanisms in the VTA have also been demonstrated to influence phasic DA
mechanisms. For instance, inhibition of NMDA receptors (NMDAR) in the VTA reduces
the frequency of naturally occurring DA transients, decreases cocaine-evoked DA release
and attenuates phasic DA encoding of reward-predictive cues during ICSS behavior
(Sombers et al., 2009). More specifically, genetic inactivation of the essential NR1 subunit
of the NMDAR selectively on midbrain DA neurons attenuates both burst firing of DA
neurons in the VTA/SN and phasic DA transients in the striatum (Zweifel et al., 2009).
Importantly, disruption of burst firing of DA neurons and phasic DA signaling observed in
those transgenic mice selectively attenuated learning of many tasks in which cues predicted
rewarding or aversive events (Zweifel et al., 2009, Zweifel et al., 2011). However, NR1
deletion on DA neurons does not impact the learning of a conditioned approach in response
to cue associated with reward (Parker et al., 2010). Together, the data from these studies
suggests that the NMDAR-dependent DA cell burst firing and phasic DA signaling might
play an important role in learning contingencies and encoding valence and/or salience of
important environmental cues, but is not essential for stimulus-response (S-R) associations
(Parker et al., 2010).
5.4. Phasic DA signaling and reward
A growing body of literature examining DA signaling in freely moving rats continues to
delineate the complex role of DA in reward mechanisms. For instance, the frequency of
naturally occurring phasic DA in rat dorsal and ventral striatum has been shown to increase
in response to rewarding events such as novelty, social interaction, and experimenter
delivered or self-administered drugs of abuse (Rebec et al., 1997, Robinson et al., 2001,
Robinson et al., 2002, Phillips et al., 2003b, Cheer et al., 2004, Robinson and Wightman,
2004, Stuber et al., 2005b). Interestingly, cues associated with both natural and
pharmacological rewards produce time-locked DA transients in the NAc (Phillips et al.,
2003b, Roitman et al., 2004, Day et al., 2007, Owesson-White et al., 2008). Similarly, DA
transients also occur in the NAc shell during intracranial self-stimulation (ICSS) in response
to the intracranial stimulus as well as to the conditioned stimuli that predict reward
availability (Cheer et al., 2007). Furthermore, phasic DA contributes to the maintenance of
self-administration behavior, as DA transients in the NAc core precede lever depression in
rats trained for cocaine self-administration and electrically evoked phasic DA release is
sufficient to promote cocaine self-administration behavior (Phillips et al., 2003b, Stuber et
al., 2005b). These observations suggest that phasic DA may play a crucial role in incentive
learning and goal-directed behaviors and are consistent with the idea that DA modulates
reward-seeking behaviors (Goto and Grace, 2005, Nicola et al., 2005, Morris et al., 2006).
Interestingly, recent evidence points to a selective role of phasic DA in NAc in encoding
anticipated benefits but not costs to obtain food reward in rats trained on a decision-making
task (Gan et al., 2010). Similarly, the magnitude of the cue-elicited phasic DA firing and
release has been shown to depend on the size of the reward, the time to reward delivery and
the probability of receiving a reward (Fiorillo et al., 2003, Beyene et al., 2010). In contrast,
aversive stimuli such as quinine taste, stimuli conditioned with electric shock, or delayed
cocaine availability modulates phasic DA signaling by producing a decrease in phasic DA
levels detected with FSCV (Wheeler et al., 2011, Zweifel et al., 2011). These observations
suggest that phasic DA might encode the attribution of salience and/or valence to the
environmentally salient stimuli. Taken together, the data suggest that phasic DA signaling
plays an important role in reinforcement learning.
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5.5. Phasic DA and reinforcement learning
Several lines of evidence point to a role for phasic DA in reinforcement learning. During
Pavlovian training for food reward, both burst firing of midbrain DA neurons and phasic DA
transients in NAc shift from primary reward to the reward-predictive stimulus (Schultz,
1998, Day et al., 2007). This phasic DA plasticity is also apparent during ICSS training with
a conditional stimulus (CS). Initially, DA transients are only seen at ICSS delivery.
However, with increasing number of repeated parings with the CS and ICSS delivery, DA
transients begin to emerge and increase in response to CS – a process proposed to underlie
S-R (stimulus-response) associative learning. Furthermore, ICSS extinction leads to the
decrease and eventual elimination of CS-evoked DA transients across trials – an effect
accompanied by significant decline in goal-directed behaviors. Furthermore, reinstatement
of ICSS behavior is accompanied by the return of DA transients to pre-extinction amplitudes
in response to the CS (Owesson-White et al., 2008). Such results, showing that phasic DA
release is associated with a CS that predicts reward, are in line with theories of reward-
prediction error, in which DA neurons responsiveness encodes the predictive value of
stimuli during associative learning (Schultz et al., 1997). More recently, increased phasic
DA encoding during S-R learning has also been demonstrated to reflect the incentive
salience of the CS (Flagel et al., 2011).
Additional evidence also points to the role of phasic DA in reinforcement learning as
pharmacological and genetic disruption of DA D1R signaling – which is thought to arise
from phasic DA - impairs acquisition of S-R associations (Lisman and Grace, 2005, Grace et
al., 2007). Interestingly, DA-deficient mice are capable of learning the S-R association but
lack the motivation to work for food reward. In addition, hyperdopaminergic mice can learn
an instrumental task as fast as controls but exhibit increased motivation to work for food
reward (Hnasko et al., 2005, Cagniard et al., 2006). Such results suggest the possibility that
DA is not necessary for attributing salience and/or valence to environmentally-relevant cues
but is instead more important for encoding motivation to obtain the reward. Importantly not
all forms of S-R learning require phasic DA signaling. Sign-tracking behavior, where an
animal will first approach and seek the CS cue, (the “sign” that is associated with reward) is
dependent on phasic DA signaling. In contrast, goal-tracking behavior, where an animal
approaches the reward or reward location (the “goal”) after CS presentation and not the CS
itself, is not dependent on phasic DA release. In both cases, the CS is a strong predictor of
the reward delivery and evokes a conditional approach behavior. However, a shift in phasic
DA signaling to the CS is only present in sign-trackers and is absent in goal-trackers. In
addition, the systemic blockade of DA transmission suppresses sign-tracking but not goal-
tracking behaviors (Flagel et al., 2011). These results indicate that DA signaling may
underlie a form of an S-R learning in which incentive salience is assigned to a CS, as is
observed in sign-trackers, rather than encoding a predictive error signal.
5.6. Phasic DA signaling, drugs of abuse, and drug-mediated behavior
While microdialysis studies demonstrate that alcohol, nicotine, opiates, psychostimulants,
and cannabinoids, increase DA levels (Wise and Bozarth, 1987, Di Chiara and Imperato,
1988), recent in vivo FSCV studies have highlighted the importance of phasic DA signaling
physiological responses to cocaine and in cocaine-mediated behavior. While cocaine self-
administration behavior is mediated by cocaine inhibition of the DAT (Ritz et al., 1988),
cocaine also increases phasic DA release, in freely moving rats and this is likely a
consequence of phasic firing of the VTA DA neurons (Wightman et al., 2007). Interestingly,
cocaine-induced increases in phasic DA release are more pronounced in the shell of NAc in
comparison to the NAc core (Aragona et al., 2008). This subregion difference is due to DA
autoreceptor function, since it is abolished by DA D2 autoreceptor blockade before cocaine
administration. These observations implicate that cocaine directly increases DA release in a
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regionally specific manner and demonstrates the significance of autoregulation in cocaine-
evoked DA transmission (Aragona et al., 2008, Aragona et al., 2009).
FSCV studies in freely moving rats have also shown that i.v. cocaine produces increases in
DA concentration in the NAc as fast as 20–40s after the end of cocaine infusion (Mateo et
al., 2004, Heien et al., 2005, Stuber et al., 2005a). This DA rise in concentration is readily
observed in the shell but not core of the NAc (Aragona et al., 2008). This delay is thought to
reflect the time-course for cocaine to cross the blood-brain barrier. However, it has been
demonstrated that DA transients occur faster in animals which are well trained in cocaine
self-administration (Stuber et al., 2005a). These DA transients are observed as early as 0–2 s
after cocaine i.v. infusion, followed by a second DA rise occurring 2–8 s later (Stuber et al.,
2005a, Aragona et al., 2008, Wise and Kiyatkin, 2011). The first DA peak after cocaine i.v.
infusion reflects DA response to external cues such as the sound of the lever press or the
onset of audiovisual cues (such tone or cue light), whereas the second DA peak is thought to
be associated with interoceptive cocaine effects in periphery (Aragona et al., 2008, Wise and
Kiyatkin, 2011). Consistent with the evidence for phasic DA in reinforcement learning,
these observations indicate that, after conditioning, both external and internal cues can serve
as predictive cues of the later unconditioned cocaine effect on the DA neurotransmission. In
contrast, if the CS predicts a delay in cocaine availability, it produces a decrease in DA
concentration associated with aversive state, whereas DA concentration rapidly increase in
response to cues signaling imminent cocaine delivery in the subsequent self-administration
session (Wheeler et al., 2011). These findings show rapid, bivalent contextual control over
brain reward processing.
During cocaine self-administration behavior, DA transients occur in the NAc core both pre-
and post-response (ie lever depression resulting in i.v. cocaine administration and cue
presentation). The pre-response DA transients are associated with the lever approach,
whereas post-response DA peaks are time-locked to cocaine predictive cues, as discussed
above. Furthermore, pre-response DA appears to contributes to the maintenance of self-
administration behavior, as electrically evoked phasic DA release is sufficient to promote
cocaine self-administration behavior (Phillips et al., 2003b, Stuber et al., 2005a).
Interestingly, only the post-response DA release is subject to change in response to
extinction or reinstatement procedures (Stuber et al., 2005b). Therefore, changes in phasic
DA signaling appear to reflect associative processes linking cues with drug rewards. These
observations suggest that phasic DA may play a crucial role in incentive learning and goal-
directed behaviors and are consistent with the idea that DA modulates reward-seeking
behaviors (Goto and Grace, 2005, Nicola et al., 2005, Morris et al., 2006).
5.7. Other mechanisms for phasic DA modulation
Several lines of evidence suggest that norepinephrine (NE) signaling in VTA modulates DA
neuronal activity and DA release at terminals. It has been demonstrated that (i) the locus
ceruleus – a major source of NE in the CNS - projects to the VTA (Jones et al., 1977,
Geisler and Zahm, 2005); (ii) NE terminals make synaptic contacts onto midbrain DA
neurons (Liprando et al., 2004); (iii) α-1 and α-2 adrenoceptors are present within the VTA
(Jones et al., 1985, Lee et al., 1998) and (iv) blockade of α-1 adrenoceptors as well as
activation of α-2 adrenoceptors reduces burst firing in DA cells (Grenhoff and Svensson,
1988, 1989, Grenhoff et al., 1993). These observations suggest that the NE system may
modulate phasic DA signaling. The orexin/hypocretin system is also capable of modulating
phasic DA release. Afferent projections from the lateral hypothalamus provide the source of
orexin in the VTA (Harris et al., 2005, Narita et al., 2006, Zheng et al., 2007). In addition,
orexin release onto VTA neurons activates DA cells and produces DA release at the DA cell
terminal fields (Narita et al., 2006, Vittoz and Berridge, 2006, Muschamp et al., 2007, Vittoz
et al., 2008). Furthermore, orexin signaling facilitates cocaine-induced glutamate-dependent
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LTP in the VTA (Borgland et al., 2009). Several lines of evidence suggest a role for orexin
in reward-seeking behavior (Harris et al., 2005, Narita et al., 2006, Zheng et al., 2007).
Blockade of VTA orexin signaling decreases both basal and cocaine-evoked phasic DA
release in NAc core as well as motivation to self-administer cocaine (Espana et al., 2010). In
addition, activation of the orexin system by hypocretin-1 infusion into the VTA increases
the effects of cocaine on tonic and phasic DA signaling as well as the motivation to self-
administer cocaine (Espana et al., 2011).
Phasic DA release can also be modulated by facilitation of activity at DA terminals.
Glutamatergic afferents originating from basolateral amygdala (BLA) and forming synapses
with NAc DA terminals are capable of modulating phasic DA release (Floresco et al., 1998).
Such BLA inputs are crucial for processing motivationally salient stimuli during reward-
seeking (Jones et al., 2010). Another system that can modulate phasic DA is the opiod
system via the kappa opioid receptors (KOR) located presynaptically within DA terminals or
on DA midbrain cells bodies (Mansour et al., 1995, Svingos et al., 2001). Activation of the
KOR by systemic administration of the KOR agonist, salvinorin A, decreased phasic DA
release in both NAc core and shell and resulted in attenuated motivation to obtain reward
(Ebner et al., 2010). The role of the cannabinoid system has also been investigated as the
CB1 receptor agonist, WIN55,212-2, increases both the number of spikes in a burst and the
frequency of burst firing of VTA DA cells (Cheer et al., 2003). Similarly, intravenous
administration of the CB1 agonist increases both the rate of DA transients as well as DA
concentration detected with FSCV in the NAc, an effect blocked by a CB1 antagonist (Cheer
et al., 2004). These observations suggest that phasic DA signaling is controlled and
modulated by multiple neurotransmitter systems at the level of DA cell bodies and the DA
terminals. Such a complex network is suited to control sub-second DA release in response to
salient environmental stimuli, and therefore, is a crucial component of the reward system of
the brain. Phasic DA signaling leads to goal-directed behaviors which favor survival in the
changing environment. On the other hand, it may also underlie pathological conditions
which may lead to psychiatric disorders such as schizophrenia and addiction.
6. Conclusions
The brain DA system and its relation to reward and addiction have been studied extensively
since initial findings showing its role for ICSS and reward circuitry. The mesocorticolimbic
DA system, consisting of VTA/SN DA neurons which send projections to limbic (ventral
and dorsal striatum, amygdala, hippocampus) and cortical sites (medial prefrontal cortex,
orbitofrontal cortex, cingulate cortex), has been implicated in processing salient stimuli and
influencing goal-directed behaviors. DA signaling has been shown to be involved in both
reinforcement learning and habit formation (Schultz et al., 1997). The use of electrochemical
techniques (microdialysis, amperometry, chronoamperometry, FSCV and RDV) and as well
as radiolabeling techniques, both in the in vitro and in vivo preparations has established a
broad foundation for DA system physiology. Improvements in the electrochemical detection
sensitivity have allowed for analysis of 10 nM DA fluctuations with very high spatial and
temporal resolution (Robinson et al., 2003), providing an excellent tool to study DA release
dynamics. Thus, combined results from electrophysiological and electrochemical studies
have allowed for the distinction of tonic and phasic DA activity. Results obtained with
electrochemical techniques such as FSCV, strengthened many electrophysiological findings
which suggested a role for DA neurons burst firing in the processing of reward and reward
associated stimuli. In addition, FSCV allows for the distinction and examination of in vivo
DA release and uptake kinetics providing insight into the changes of DA signaling caused
by presynaptic plasticity (e.g. evoked by psychostimulant treatment) (Greco and Garris,
2003, Addy et al., 2010). Finally, the use of FSCV in freely moving animals has allowed for
functional determination of in vivo, real time DA release. These studies point to the crucial
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role of phasic DA signaling in the NAc – the brain motivation-action interface in the process
of reinforcement learning. While phasic DA signaling has been postulated to encode
prediction error signals, recent findings also suggested its role in encoding salience of
environmental stimuli as well as motivation to work for reward. Importantly, changes in
phasic DA signaling in NAc during drug self-administration, extinction and reinstatement
may underlie the mechanisms of how drug-associated cues influence different phases of
addiction including drug-seeking behavior during drug-taking and abstinence.
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Figure 1.
Temporal versus spatial resolution plot of five commonly used techniques to monitor DA
levels. Values plotted are typical and not theoretical ranges. Inset: Ranking of sensitivity of
each of these five techniques. A greater number of asterisks indicate greater sensitivity.
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